(1)An antibody named P85-Ab within EBV exhibited high sensitivity (95%CI:86.4-97.8) and specificity (95%CI:97.8-99.9) in the screening of NPC (2);Activate the p62-Keap1-NRF2 signaling pathway and reduce the sensitivity of nasopharyngeal cancer cells to ferroptosis (3);The latent membrane protein 1 (LMP1) encoded by EBV enhances the anti-apoptotic ability of nasopharyngeal carcinoma cells (4);LMP1 induces immune evasion. This evidence concerns the gene KEAP1 and nasopharyngeal carcinoma.